References
- WHO website. [consulted 2021 Jan 17]. Available from: www.who.int/docs
- Lechien JR, Chiesa-Estomba CM, Hans S, et al. Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern Med. 2020; 173:672–675.
- Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15:e0234765.
- Bhattacharyya N, Kepnes LJ. Contemporary assessment of the prevalence of smell and taste problems in adults. Laryngoscope. 2015;125:1102–1106.
- World Health Organization. 2020. Clinical management of COVID-19: interim guidance. World Health Organization. (No. WHO/2019-nCoV/clinical/2020.5).
- Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018; 27:1159–1170.
- Cappelleri JC, Zou KH, Bushmakin AG, et al. Patient-reported outcomes: measurement, implementation and interpretation. Boca Raton (FL): Chapman and Hall/CRC; 2013.
- de Dorlodot C, Horoi M, Lefebvre P, et al. French adaptation and validation of the sino-nasal outcome test-22: a prospective cohort study on quality of life among 422 subjects. Clin Otolaryngol. 2015; 40:29–35.
- Krajewska J, Krajewski W, Zub K, et al. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020; 277:1885–1897.
- Lechien JR, Chiesa-Estomba CM, Beckers E, et al. Prevalence and recovery of olfactory dysfunction: a multicenter study of 1,363 COVID-19 patients. J Int Med. 2020.
- Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92:1902–1914.
- de Terwangne C, Laouni J, Jouffe L, et al., on behalf of EPIBASE TEAM. Predictive accuracy of COVID-19 World Health Organization (WHO) Severity Classification and comparison with a Bayesian-Method-Based Severity Score (EPI-SCORE). Pathogens. 2020;9:880.
- Bartoletti M, Giannella M, Scudeller L, et al. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020;26:1545–1553.
- Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51:843–851.
- Lee Y, Min P, Lee S, et al. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35:e174.
- Ninchritz-Becerra E, Soriano-Reixach MM, Mayo-Yánez M, et al. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Medicina Clinica. 2021;156:61–64.
- Bastiani L, Fortunato L, Pieroni S, et al. Rapid COVID-19 screening based on self-reported symptoms: psychometric assessment and validation of the EPICOVID19 Short Diagnostic Scale. J Med Internet Res. 2021;23:e23897.
- Lechien JR, Chiesa-Estomba CM, Varia LA, et al. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021.
- Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26:e928996.
- Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg. 2019;160:762–782.
- Lechien JR, Bobin F, Muls V, et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring. Eur Arch Otorhinolaryngol. 2020;277:511–520.
- Jiang G, Cai Y, Yi X, et al. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: a retrospective study. J Med Virol. 2020;92:2124–2129.